132 related articles for article (PubMed ID: 32056515)
1. Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter.
Lehmacher M; Stolzenburg A; Samnick S
Curr Cancer Drug Targets; 2020; 20(2):146-155. PubMed ID: 32056515
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNIS.
Weeks AJ; Jauregui-Osoro M; Cleij M; Blower JE; Ballinger JR; Blower PJ
Nucl Med Commun; 2011 Feb; 32(2):98-105. PubMed ID: 21085047
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
Jiang H; Bansal A; Pandey MK; Peng KW; Suksanpaisan L; Russell SJ; DeGrado TR
J Nucl Med; 2016 Sep; 57(9):1454-9. PubMed ID: 27103021
[TBL] [Abstract][Full Text] [Related]
4. 18F-Fluorosulfate for PET Imaging of the Sodium-Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo.
Khoshnevisan A; Chuamsaamarkkee K; Boudjemeline M; Jackson A; Smith GE; Gee AD; Fruhwirth GO; Blower PJ
J Nucl Med; 2017 Jan; 58(1):156-161. PubMed ID: 27539841
[TBL] [Abstract][Full Text] [Related]
5. [
Jiang H; DeGrado TR
Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
[TBL] [Abstract][Full Text] [Related]
6.
O'Doherty J; Jauregui-Osoro M; Brothwood T; Szyszko T; Marsden PK; O'Doherty MJ; Cook GJR; Blower PJ; Lewington V
J Nucl Med; 2017 Oct; 58(10):1666-1671. PubMed ID: 28385795
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter.
Jauregui-Osoro M; Sunassee K; Weeks AJ; Berry DJ; Paul RL; Cleij M; Banga JP; O'Doherty MJ; Marsden PK; Clarke SE; Ballinger JR; Szanda I; Cheng SY; Blower PJ
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2108-16. PubMed ID: 20577737
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of
Jiang H; Bansal A; Goyal R; Peng KW; Russell SJ; DeGrado TR
Bioorg Med Chem; 2018 Jan; 26(1):225-231. PubMed ID: 29198608
[TBL] [Abstract][Full Text] [Related]
9. Tracking dendritic cell migration into lymph nodes by using a novel PET probe
Lee SB; Lee HW; Lee H; Jeon YH; Lee SW; Ahn BC; Lee J; Jeong SY
EJNMMI Res; 2017 Dec; 7(1):32. PubMed ID: 28378292
[TBL] [Abstract][Full Text] [Related]
10. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
Samnick S; Al-Momani E; Schmid JS; Mottok A; Buck AK; Lapa C
Clin Nucl Med; 2018 Mar; 43(3):162-167. PubMed ID: 29356744
[TBL] [Abstract][Full Text] [Related]
11. [
Diocou S; Volpe A; Jauregui-Osoro M; Boudjemeline M; Chuamsaamarkkee K; Man F; Blower PJ; Ng T; Mullen GED; Fruhwirth GO
Sci Rep; 2017 Apr; 7(1):946. PubMed ID: 28424464
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of [
Niu M; Qin J; Wang L; He Y; Tian C; Chen Y; Huang P; Peng Z
Mol Imaging; 2022; 2022():2679260. PubMed ID: 35330799
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression.
Chen L; Altman A; Mier W; Lu H; Zhu R; Haberkorn U
Nucl Med Biol; 2006 May; 33(4):575-80. PubMed ID: 16720251
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
[TBL] [Abstract][Full Text] [Related]
15. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
16. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
18. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
Unterholzner S; Willhauck MJ; Cengic N; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2006 Jan; 91(1):69-78. PubMed ID: 16234306
[TBL] [Abstract][Full Text] [Related]
20. Safety, pharmacokinetics, metabolism and radiation dosimetry of
Jiang H; Schmit NR; Koenen AR; Bansal A; Pandey MK; Glynn RB; Kemp BJ; Delaney KL; Dispenzieri A; Bakkum-Gamez JN; Peng KW; Russell SJ; Gunderson TM; Lowe VJ; DeGrado TR
EJNMMI Res; 2017 Oct; 7(1):90. PubMed ID: 29080017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
